Harvey Luksenburg, Ph.D. National Heart, Lung, & Blood Institute two years of the initial event. The NIH’s Role in the Prevention and Reduction of Strokes.

Slides:



Advertisements
Similar presentations
Summary Prepared by Melvyn Rubenfire, MD
Advertisements

A presentation by: 1.  Aging well depends on your: Genes Environment Lifestyle  Healthy lifestyle choices may help you maintain a healthy body and brain.
SICKLE CELL ANEMIA.
Sickle Cell Anemia Roxbury Community College ADN 253 Honors Presentation Adanna Uwandu, Shadia Laurent, Salwa Said 05/01/07.
By: Alejandra Arellano
Sickle Cell Anemia Columbia County Medical Assistant Association.
Fetal alcohol syndrome
STRIVE HEALTH MENTORING Sickle cell Teens Raising awareness, Initiating change, Voicing opinions and Empowering themselves! Volunteer Recruitment Information.
Stroke Mark Sudlow Consultant and Senior Lecturer
Wellness S Y M P O S I U M Darwin R. Labarthe, MD, MPH, PhD Director, Division for Heart Disease and Stroke Prevention.
Stirling, June 2009 Newborn Sickle Screening Programme – Clinical Pathways in Scotland. EA Chalmers Royal Hospital for Sick Children, Glasgow.
NOTES 24 – Genetic Disorders and Hereditary Diseases
Diabetes: The Numbers Michigan Diabetes Partners in Action and Michigan Department of Community Health Diabetes: The Numbers Adapted from the National.
Managing Diabetes What Is Diabetes? and Diabetes ABCs.
Stroke 101 Goals of Presentation What is a stroke? Types of stroke Warning signs of stroke Why did I have a stroke? Are there treatments for stroke?
SICKLE CELL ANEMIA Prepared by: Tuba Kartal Özge Özütrk.
Do not be a victim. What is a Stroke A stroke is the result of injury to brain tissue from lack of oxygen A stroke occurs when blood flow to the cells.
Diabetes: The Numbers The National Diabetes Education Program A joint program of NIH and CDC January 2007 Diabetes: The Numbers The National.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
North West London Haemoglobinopathy Managed Clinical Network Lola Oni Professional Services Director/ Lecturer Brent Sickle Cell & Thalassaemia Centre.
Face Stroke, Before it Faces You Welcome. Introduction Do you know a friend or relative who has had a stroke, or have you ever had a stroke yourself?
7 Hypertension 1. Definition 2 High blood pressure is called the "silent killer" because many people don't realize they have it. High blood pressure.
Clinical aspects of sickle cell and thalassaemia Dr.Beverley Robertson Consultant Haematologist NHS Grampian.
Understanding Heart Disease In this lesson, you will Learn About… Different types of heart disease. How heart disease is treated. What you can do to reduce.
Sickle Cell Disease: Core Concepts for the Emergency Physician and Nurse Acute Stroke Laura Moore, BS, RN Duke University School of Nursing Paula Tanabe,
Genetic Diseases (1)Sickle-cell anaemia 鐮刀形紅血球貧血症.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
MARCH 17, 2011 Morning Report. Sickle Cell Disease Chronic hemolytic anemia Multiple hemoglobin variants  SS  SC  S-beta thal One of the most common.
Hydroxyurea For the Management of Childhood SCD in Kenyan County Hospitals Hydroxyurea for SCD Panel.
By: Glenna, Savannah, and Chris
Haemoglobinopathies.
Randomized Trial of Ea rly S urgery Versus Conventional Treatment for Infective E ndocarditis (EASE) Duk-Hyun Kang, MD, PhD on behalf of The EASE Trial.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Do not be a victim. Who is at risk? Everyone is at risk but some persons have higher risk than others.
Epidemiology, Genetics, Pathophysiology Spring 2013
CARDIOVASCULAR DISEASES Heart Attack Definition- is the death of part of the heart muscle caused by lack of blood flow to the heart. A heart attack can.
SICKLE CELL ANEMIA Omar and Yassin.
PROTECT Progesterone for Traumatic brain injury. What was the PROTECT study? Multicenter Moderate to severe trauma to the brain Patients enrolled within.
Prevention Of Diabetes. Type 2 Diabetes: Hyperglycemia Insulin Resistance Relative Impairment of Insulin Secretion Pathogenesis: Poorly Understood Genetic.
Stroke by: Katarina Batinjan Mentor: A. Ž mega č Horvat.
Health Mrs. Wagner.  Genetic – Hereditary – carried on Recessive Gene – must have 2 recessive genes to get birth defect  Chromosomal – 23 pairs from.
1 Sickle Cell Disease. 2 Bone marrow produces RBCs with defective hemoglobin.
Introduction to Health Checks. Learning objectives Familiarisation with the Well Persons and Well Child Health Check tool Understand the relationship.
Sickle Cell Disease By Samantha.
Sickle Cell Disease Taeron Burrell. What Is Sickle Cell Anemia? Sickle cell Anemia is a serious disorder in which the body makes sickle shape blood cells.
Closure of Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Study Thomas Scalea, MD Physician-in-Chief R Adams Cowley University of Maryland.
Safety of Cerebral Digital Subtraction Angiography in Pediatric Patients with Sickle Cell Disease. Emily Wyse, BS 1 Jessica Carpenter, MD 2 Suresh Magge,
An Ounce of Prevention  2000, 2005, 2011 The Curators of the University of Missouri Chapter 4 Tobacco.
Reducing Health Risks 6/13/ Effective ways to reduce the risks from other factors Take action to avoid or reduce known risks Obtain regular check-ups.
Substance Abuse Part I: Smoking. Studies show that cigarette smoking is most likely to become a habit during the adult years. TRUE FALSE Studies show.
Barriers to Implementation of Evidence-Based Stroke Prevention in Sickle Cell Disease: A Preliminary Study Julie Kanter, M.D. Director, Sickle Cell Research.
Sickle cell By: Journee, Nayeli, and Odalis.  Sickle cell is a red blood disorder that can cause red blood cell to change form and cause lots of pain.
Sickle-Cell Anemia Katie Baska. What is Sickle-cell Anemia? An inherited disease that results in the production of abnormal hemoglobin in red blood cells.
KAITLIN BANNON SICKLE CELL DISEASE. WHAT IS SICKLE CELL DISEASE? WHERE DID IT COME FROM?
Straight Talk with Larenz Tate T he term sickle cell disease (SCD) describes a group of inherited red blood cell disorders. People with SCD have abnormal.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection The INSIGHT START Study Group Ben Andres Oct 15, 2015.
Human Genetic Disorders Human Genetics and Genetic Technology.
Sickle Cell Anemia Jeff Bonebrake.  Overview  Signs and Systems  Causes  Risk Factors  Screening and Diagnosis  Complications  Treatment  Prevention.
Summary of “A randomized trial of standard versus intensive blood-pressure control” The SPRINT Research Group, NEJM, DOI: /NEJMoa Downloaded.
Chronic diseases account for seven out of ten deaths in the United States. That is the bad news. The good news is that chronic disease is largely preventable.
3.1 Review PBS.
E. Steve Roach, M. D. Robert & Edgar Wolfe Foundation
Cardiac arrest & Reactivation
3.1 Review PBS.
Diseases and Disorders of the Circulatory System
Disorders of the Circulatory System
Comprehensive Care Model: A Model for Sickle Cell Disease Management
HSCT in children with sickle cell Disease
Presentation transcript:

Harvey Luksenburg, Ph.D. National Heart, Lung, & Blood Institute two years of the initial event. The NIH’s Role in the Prevention and Reduction of Strokes in Children with Sickle Cell Disease ( )

Stroke in Children with Sickle Cell Disease  Stroke is a leading cause of death and disability in both children and adults with SCD.  The risk of having a stroke up until the age 20 years is 11%.  This risk is about 300 times higher than seen in children without SCD.  Recurrent stroke occurs in about two-thirds of children within two years of the initial event.

 TCD is a non-invasive test that measures the velocity of blood flow in large vessels of the brain.  TCD is used to identify children with a high risk of stroke. Transcranial Doppler Ultrasonography (TCD)

 Children with a high risk for stroke (TCD) were randomized to receive either regular blood transfusions or standard supportive care.  After one year 10 children in the standard care group had a stroke, but only one child in the transfusion group had a stroke.  This represented a 90% decline in the stroke rate. The Stroke Prevention Trial in Sickle Cell Disease (STOP) ( )

 As a result of these findings, NIH recommended that the study be terminated one year early.  Recommendations: children with SCD who are identified at high risk for stroke should receive regular red cell transfusions. STOP Trial

 STOP 2 Trial (2005): If TCD normalizes can transfusions be discontinued?  Children receiving transfusions for stroke prevention for at least 30 months.  Randomized to either continued transfusion or no transfusion. How Long Should Transfusions Be Given?

 In the group that had transfusion stopped, 14 developed a high TCD (high risk for stroke) and 2 had strokes.  In the group that continued transfusion, no child developed either a stroke or a high TCD.  Conclusion: Transfusion should be continued indefinitely in children at high risk for stroke. STOP 2--Results

 Children’s Hosp. of Philadelphia reported a 90% reduction in acute strokes in children through a program of TCD screening and transfusion.  This resulted in an increase in the number of children receiving regular blood transfusions. J.Pediatrics 2010 Reduction in Stroke in Children

 Can strokes in children be prevented by hydroxyurea (instead of transfusions)?  What are the optimal ways to predict and treat stroke in adults? Questions for Further Research;